Regeneron Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 04 Aug 22 | SellUS$4,251,188 | Arthur Ryan | Individual | 6,840 | US$622.06 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| State or Government | 59,367 | 0.06% |
| Individual Insiders | 4,487,372 | 4.2% |
| General Public | 7,953,501 | 7.4% |
| Institutions | 94,610,014 | 88.3% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 9,418,300 | $6.8b | 2.74% | 0.15% | |||
| 9,084,606 | $6.6b | -15.05% | 0.57% | |||
| 8,852,107 | $6.4b | 1.49% | 0.13% | |||
| 8,554,563 | $6.2b | 7.85% | 0.39% | |||
| 5,614,025 | $4.1b | 4.31% | 0.65% | |||
| 4,893,616 | $3.5b | -1.36% | 0.18% | |||
| 2,409,581 | $1.7b | 0% | no data | |||
| 2,384,701 | $1.7b | 7.27% | 0.92% | |||
| 2,217,993 | $1.6b | 0.45% | 0.19% | |||
| 2,178,232 | $1.6b | 26.37% | 0.18% | |||
| 1,767,919 | $1.3b | -26.83% | 0.23% | |||
| 1,312,407 | $951.6m | -1.89% | 1.66% | |||
| 1,265,120 | $917.3m | -1.31% | no data | |||
| 1,165,317 | $844.9m | 4.28% | 1.29% | |||
| 1,154,573 | $837.1m | -0.81% | 0.16% | |||
| 992,067 | $719.3m | 0.95% | 0.16% | |||
| 966,467 | $700.7m | 0% | 0.08% | |||
| 961,710 | $697.3m | -12.73% | 0.48% | |||
| 849,127 | $615.7m | 2.14% | 0.18% | |||
| 775,691 | $562.4m | 11.02% | 0.16% | |||
| 768,028 | $556.9m | 2.86% | 0.1% | |||
| 688,879 | $499.5m | 6.04% | 0.47% | |||
| 633,508 | $459.3m | -0.17% | 0.1% | |||
| 612,886 | $444.4m | 1.27% | 0.17% | |||
| 595,604 | $431.8m | 1.48% | 0.1% |